Gyre Therapeutics, Inc. GYRE Cash Flow Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| —— | $17.9M+121% | -$85.48M-937% | -$8.24M+90.6% | ||
| $2.48M+60.2% | $1.55M+44.2% | $1.07M-1.2% | $1.09M+275% | ||
| $7.16M+761% | $831K-88.6% | $7.28M-45.5% | $13.37M+293% | ||
| —— | —— | $25.89M+143% | $10.68M+113% | ||
| $1.19M-50.0% | $2.38M-72.1% | $8.52M+70.9% | $4.99M— | ||
| —— | -$19.88M+5.8% | -$21.1M-52.7% | -$13.81M-129% | ||
| $24.38M+1,060% | $2.1M-15.9% | $2.5M— | —— | ||
| —— | -$21.7M-360% | $8.33M— | —— | ||
| -$180K— | —— | $17.38M+205% | $5.69M— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Gyre Therapeutics, Inc. generate?
- Gyre Therapeutics, Inc. (GYRE) generated $9.8M in operating cash flow over the trailing twelve months.
- What is Gyre Therapeutics, Inc.'s free cash flow?
- After $1.2M of capital expenditures, Gyre Therapeutics, Inc.'s free cash flow was $3.1M over the trailing twelve months, up 142.4% year over year.
- Where does Gyre Therapeutics, Inc.'s cash flow data come from?
- Every line is extracted from Gyre Therapeutics, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
